Vivian Jiang

Vivian Jiang is a Senior Professor at The University of Texas MD Anderson Cancer Center. Her research focuses on lymphoid neoplasia, specifically mantle cell lymphoma and other hematological malignancies, with an emphasis on therapeutic targets, tumor biology, and immunology. Her recent work explores immune system states shaping clinical responses to CAR-T therapy, TCA cycle metabolic switches in pirtobrutinib-tolerant persister cells, and BCL-2/BCL-XL dual inhibition inducing Gasdermin D-mediated pyroptosis. She has also contributed to developing novel CDK9 inhibitors and protein degraders for aggressive lymphomas, alongside integrative profiling strategies for personalized therapy. Her publications appear in venues such as *Blood*, *Cancer Research*, and *npj Precision Oncology*.